Study Comparing CT Scan and Stress Test in Diagnosing Coronary Artery Disease in Patients Hospitalized for Chest Pain (PROSPECT)

August 21, 2015 updated by: Jeffrey Levsky, Montefiore Medical Center

A Randomized Trial Comparing Multi-Detector Coronary CT Angiography and Stress Myocardial Perfusion Imaging as the Initial Test for the Diagnosis of Coronary Artery Disease in Intermediate Risk Patients Admitted for Chest Pain

The purpose of this study is to determine whether coronary artery CT scanning or nuclear stress testing is better at diagnosing chest pain patients with coronary artery disease to select appropriate candidates for coronary catheterization and re-vascularization.

Study Overview

Study Type

Interventional

Enrollment (Actual)

400

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Bronx, New York, United States, 10467
        • Moses Division, Montefiore Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patient admitted for chest pain or pressure
  • patient at intermediate short term risk of MI or death (AHA/ACC guidelines)

Exclusion Criteria:

  • prior diagnosis of coronary artery disease
  • evidence of ongoing myocardial infarction (and other high risk criteria per AHA/ACC guidelines)
  • contraindications to EKG-gated CT scanning with iodinated intravenous contrast under beta-blockade
  • pregnancy
  • presence of an implanted pacemaker or defibrillator
  • stress myocardial perfusion imaging, coronary CTA or coronary catheterization within the last 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CTA
Initial EKG-gated computed tomography angiography of the coronary arteries
64-detector, retrospectively EKG-gated, computed tomography angiography of the coronary arteries during heart rate control (intravenous metoprolol, when necessary)
Other Names:
  • CCTA
  • Coronary CTA
  • Coronary CT
  • Coronary Artery CT
  • Coronary Artery CTA
  • Coronary CT Angiography
  • CTA of the Coronary Arteries
Active Comparator: MPI
Initial nuclear stress myocardial perfusion imaging
Usually dual-isotope perfusion imaging at rest (201-Thallium) and at stress (99m-Technetium-MIBI). Some patients will have a 2-day MIBI protocol. Gated SPECT and attenuation-correction images will be obtained. Treadmill stress will be performed. If a patient is unable to exercise, adenosine or dobutamine will be given.
Other Names:
  • stress test
  • sestamibi
  • nuclear stress test
  • nuclear cardiology
  • nuclear perfusion imaging
  • dual-isotope stress test
  • thallium
  • myocardial perfusion imaging
  • gated SPECT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Coronary catheterization that does not lead to re-vascularization
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
Length of Hospital Stay (time to discharge)
Time Frame: usually from hours to a few days (average about one day)
usually from hours to a few days (average about one day)
Non-fatal myocardial infarction
Time Frame: 1 year
1 year
Death (all cause)
Time Frame: 1 year
1 year
Post-test renal dysfunction
Time Frame: usually within a few days
usually within a few days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeffrey M Levsky, MD, PhD, Montefiore Medical Center/Albert Einstein College of Medicine
  • Study Director: Linda B Haramati, MD, MS, Montefiore Medical Center/Albert Einstein College of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2008

Primary Completion (Actual)

March 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

June 24, 2008

First Submitted That Met QC Criteria

June 24, 2008

First Posted (Estimate)

June 26, 2008

Study Record Updates

Last Update Posted (Estimate)

August 25, 2015

Last Update Submitted That Met QC Criteria

August 21, 2015

Last Verified

August 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Coronary Computed Tomography Angiography

Subscribe